Corient Private Wealth
LENZ

Corient Private Wealth’s LENZ Therapeutics LENZ Stock Holding History

Corient Private Wealth’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$426K Buy
74,931
+37,672
+101% +$304K ﹤0.01% 2345
2026
Q1 		$341K Buy
+37,259
New +$523K ﹤0.01% 2251
2025
Q4 		– Sell
-28,259
Closed -$1.32M – 2825
2025
Q3 		$1.32M Buy
+28,259
New +$1.04M ﹤0.01% 1285

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Corient Private Wealth's LENZ Position: Q2 2026 in Review

Corient Private Wealth increased its LENZ Therapeutics (LENZ) stake by 101% in Q2 2026, buying an estimated $304K and bringing the position to 74,931 shares worth $426K. The position accounts for ﹤0.01% of the portfolio, ranked #2345.

Corient Private Wealth first reported a position in LENZ in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.32M in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Corient Private Wealth held 74,931 shares of LENZ Therapeutics worth $426K as of Q2 2026.
  • Corient Private Wealth bought 37,672 LENZ Therapeutics shares in Q2 2026, an estimated $304K.
  • LENZ Therapeutics made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2345 holding.
  • Corient Private Wealth first reported a position in LENZ Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Corient Private Wealth's LENZ Therapeutics position peaked at $1.32M in Q3 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.